Literature DB >> 26371887

Derivation and characterization of porcine vocal fold extracellular matrix scaffold.

Emily A Wrona1, Robert Peng2, Hayley Born2, Milan R Amin2, Ryan C Branski2, Donald O Freytes1.   

Abstract

OBJECTIVES/HYPOTHESIS: To optimize decellularization of porcine vocal folds (VF) and quantify human bone marrow-derived mesenchymal stem cell (BM-MSC) interactions with this matrix to provide a foundation for regenerative approaches to VF repair. STUDY DESIGN AND METHODS: Vocal folds were dissected from porcine larynges and three decellularization protocols were compared, each consisting of washes and mechanical agitations with different combinations of reagents. DNA content was analyzed via Quant-iT Picogreen assay and hematoxylin and eosin staining. Bone marrow-derived MSCs were then seeded onto the decellularized VF matrices. Morphology, metabolic activity, DNA content, and gene expression were assessed using LIVE/DEAD Cell Viability, alamarBlue Cell Viability Assay, Quant-iT Picogreen assay, and quantitative polymerase chain reaction, respectively.
RESULTS: The most successful decellularization protocol removed 95% DNA content within 1 day, compared to several days required for previously described protocols. Histology confirmed the retention of extracellular matrix (ECM) and its components, including glycosaminoglycans, collagen, and fibrin, while void of nuclear/cellular content. Decellularized scaffolds were then seeded with BM-MSCs. Similar DNA quantities were observed after 24 hours of seeding within the VF-ECM scaffold when compared to cells on tissue culture plastic (TCP). LIVE/DEAD staining of the seeded VF-ECM confirmed excellent cell viability, and the metabolic activity of BM-MSCs increased significantly on VF-ECM compared to TCP. Endoglin gene expression decreased, suggestive of differentiation.
CONCLUSION: Porcine VFs can be efficiently decellularized within 5 hours using a combination of sodium deoxycholate and peracetic acid. Decellularized VF-ECM supported attachment and growth of human BM-MSCs, with evidence of differentiation. LEVEL OF EVIDENCE: N/A.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Vocal fold; extracellular matrix; mesenchymal stem cells; scaffold

Mesh:

Substances:

Year:  2015        PMID: 26371887     DOI: 10.1002/lary.25640

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Porcine Vocal Fold Lamina Propria-Derived Biomaterials Modulate TGF-β1-Mediated Fibroblast Activation in Vitro.

Authors:  Camilo Mora-Navarro; Andreea Badileanu; Ana M Gracioso Martins; Emily W Ozpinar; Lewis Gaffney; Ian Huntress; Erin Harrell; Jeffrey R Enders; Xinxia Peng; Ryan C Branski; Donald O Freytes
Journal:  ACS Biomater Sci Eng       Date:  2020-02-11

2.  Fast Automated Approach for the Derivation of Acellular Extracellular Matrix Scaffolds from Porcine Soft Tissues.

Authors:  Andreea Badileanu; Camilo Mora-Navarro; Ana M Gracioso Martins; Mario E Garcia; Daphne Sze; Emily W Ozpinar; Lewis Gaffney; Jeffrey R Enders; Ryan C Branski; Donald O Freytes
Journal:  ACS Biomater Sci Eng       Date:  2020-06-15

Review 3.  Tissue engineering-based therapeutic strategies for vocal fold repair and regeneration.

Authors:  Linqing Li; Jeanna M Stiadle; Hang K Lau; Aidan B Zerdoum; Xinqiao Jia; Susan L Thibeault; Kristi L Kiick
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

Review 4.  Tissue engineering applications in otolaryngology-The state of translation.

Authors:  Weston L Niermeyer; Cole Rodman; Michael M Li; Tendy Chiang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-19

5.  Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds.

Authors:  Camilo Mora-Navarro; Mario E Garcia; Prottasha Sarker; Emily W Ozpinar; Jeffrey R Enders; Saad Khan; Ryan C Branski; Donald O Freytes
Journal:  Biomed Mater       Date:  2021-11-26       Impact factor: 4.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.